Published in Clin Teach on October 01, 2013
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Attention network hypoconnectivity with default and affective network hyperconnectivity in adults diagnosed with attention-deficit/hyperactivity disorder in childhood. JAMA Psychiatry (2013) 2.11
Effects of a novel schizophrenia risk variant rs7914558 at CNNM2 on brain structure and attributional style. Br J Psychiatry (2013) 2.06
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Compliance therapy: a randomised controlled trial in schizophrenia. BMJ (2003) 1.50
The role of the major histocompatibility complex region in cognition and brain structure: a schizophrenia GWAS follow-up. Am J Psychiatry (2013) 1.48
Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Arch Gen Psychiatry (2010) 1.46
Dysbindin (DTNBP1) and the biogenesis of lysosome-related organelles complex 1 (BLOC-1): main and epistatic gene effects are potential contributors to schizophrenia susceptibility. Biol Psychiatry (2007) 1.23
Childhood stress, serotonin transporter gene and brain structures in major depression. Neuropsychopharmacology (2010) 1.12
Brain vs behavior: an effect size comparison of neuroimaging and cognitive studies of genetic risk for schizophrenia. Schizophr Bull (2012) 1.06
Nuclear receptor-mediated induction of CYP450 by antiretrovirals: functional consequences of NR1I2 (PXR) polymorphisms and differential prevalence in whites and sub-Saharan Africans. J Acquir Immune Defic Syndr (2010) 1.04
A neuropsychological investigation of the genome wide associated schizophrenia risk variant NRGN rs12807809. Schizophr Res (2010) 0.96
Insulin-like growth factor 1 (IGF1) and its active peptide (1-3)IGF1 enhance the expression of synaptic markers in neuronal circuits through different cellular mechanisms. Neurosci Lett (2012) 0.95
Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade. J Hypertens (2005) 0.92
Neurocognition and suicidal behaviour in an Irish population with major psychotic disorders. Schizophr Res (2006) 0.90
Mental state decoding v. mental state reasoning as a mediator between cognitive and social function in psychosis. Br J Psychiatry (2008) 0.86
Chitinase-3-like 1 (CHI3L1) gene and schizophrenia: genetic association and a potential functional mechanism. Biol Psychiatry (2008) 0.86
Investigation of the apolipoprotein-L (APOL) gene family and schizophrenia using a novel DNA pooling strategy for public database SNPs. Schizophr Res (2005) 0.84
A dysbindin risk haplotype associated with less severe manic-type symptoms in psychosis. Neurosci Lett (2007) 0.84
Does the ability to sustain attention underlie symptom severity in schizophrenia? Schizophr Res (2008) 0.84
The effects of psychosis risk variants on brain connectivity: a review. Front Psychiatry (2012) 0.83
The miR-137 schizophrenia susceptibility variant rs1625579 does not predict variability in brain volume in a sample of schizophrenic patients and healthy individuals. Am J Med Genet B Neuropsychiatr Genet (2014) 0.82
Neural effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253. Am J Med Genet B Neuropsychiatr Genet (2013) 0.82
The NOS1 variant rs6490121 is associated with variation in prefrontal function and grey matter density in healthy individuals. Neuroimage (2011) 0.82
A NOS1 variant implicated in cognitive performance influences evoked neural responses during a high density EEG study of early visual perception. Hum Brain Mapp (2011) 0.81
The effect of the neurogranin schizophrenia risk variant rs12807809 on brain structure and function. Twin Res Hum Genet (2012) 0.81
Effect of genetic variant in BICC1 on functional and structural brain changes in depression. Neuropsychopharmacology (2012) 0.81
Social dysfunction in schizophrenia: an investigation of the GAF scale's sensitivity to deficits in social cognition. Schizophr Res (2013) 0.81
Functional genomics and schizophrenia: endophenotypes and mutant models. Psychiatr Clin North Am (2007) 0.80
Assessing patients' beliefs about their cancer-related fatigue: validation of an adapted version of the Illness Perception Questionnaire. J Clin Psychol Med Settings (2012) 0.80
D-amino acid oxidase (DAO) genotype and mood symptomatology in schizophrenia. Neurosci Lett (2007) 0.79
Functional investigation of a schizophrenia GWAS signal at the CDC42 gene. World J Biol Psychiatry (2012) 0.79
Replicated genetic evidence supports a role for HOMER2 in schizophrenia. Neurosci Lett (2009) 0.79
Near-peer bedside clinical teaching: example of a successful programme. Clin Teach (2014) 0.78
Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide. Clin Ther (2011) 0.77
Variance in facial recognition performance associated with BDNF in schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2007) 0.77
Ribavirin and interferon alter MMP-9 abundance in vitro and in HIV-HCV-coinfected patients. Antivir Ther (2011) 0.76
Death and dignity through fresh eyes. Clin Teach (2011) 0.75
Prevalence of renal artery stenosis in flash pulmonary oedema: determination using gadolinium-enhanced MRA. Eur J Intern Med (2010) 0.75
Adherence to a Low-Support Cognitive Remediation Training Program for Psychosis. J Nerv Ment Dis (2016) 0.75
Unmet needs persist in pediatric HIV programs: lessons from selected case studies in Uganda. AIDS (2017) 0.75
Corrigendum: Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis. Nat Commun (2015) 0.75
HIV-1 Tat clade-specific cytokine induction in monocytes/macrophages is not evidenced in total or Vγ9Vδ2 T lymphocytes. AIDS (2014) 0.75